Stay updated on Tirzepatide in OSA: Clinical Trial

Sign up to get notified when there's something new on the Tirzepatide in OSA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tirzepatide in OSA: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A bibliographic entry for Sleep Med 2025 'Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA: Time course and association with body weight' was added to the Publications section. The previous 'Online ahead of print' citation for the same article was removed.
    Difference
    0.0%
    Check dated 2025-12-01T20:47:36.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added a note that publications are auto-filled from PubMed and may not be about the study. Updated the revision label to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T18:55:57.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The Taiwan site label was updated from 'Tainan City' to 'Tainan' (postal code 704) for the study location.
    Difference
    0.3%
    Check dated 2025-11-17T18:04:28.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A new reference article was added: Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA: Time course and association with body weight. Several external informational links and study documents were removed, including MedlinePlus genetics pages, DailyMed entries, specific PubMed links, vivli, and PDFs.
    Difference
    0.7%
    Check dated 2025-11-03T12:58:26.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 and added a government-operating-status notice; removed the old v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T17:37:34.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Updated to Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while keeping the revision label as the primary addition.
    Difference
    0.3%
    Check dated 2025-09-28T11:10:44.000Z thumbnail image

Stay in the know with updates to Tirzepatide in OSA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tirzepatide in OSA: Clinical Trial page.